TECHNICAL CHEMICALS TO MARKET EIGHT HEALTH TEST DIAGNOSTICS
This article was originally published in The Tan Sheet
Executive Summary
TECHNICAL CHEMICALS TO MARKET EIGHT HEALTH TEST DIAGNOSTICS -- including pregnancy and fecal occult blood tests -- approximately eight months after its initial public offering is "successfully consummated," the firm predicted in a preliminary prospectus for the IPO. Pompano Beach, Fla.-based Technical Chemicals and Products, Inc. specifically mentioned three versions of its pregnancy test, which have all received FDA clearance for over- the-counter use. Two of the tests come in a test strip format on which several drops of sample are applied, and the other test is a "midstream wand" that is dipped in urine.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning